Fluorescent-antibody reagents were prepared against vegetative cells of representative strains of each physiological group and toxin type of Clostridium botulinum known to have caused botulism in humans. A fluorescent-antibody reagent was also prepared for C. botulinum type G, which has been isolated from autopsy specimens but which has not clearly been implicated in botulism. These fluorescent-antibody reagents were evaluated against 200 strains of C. botulinum and 64 strains of other clostridia. Each reagent reacted with at least a 2 + intensity with all of the strains in its same toxin type and physiological group. Ninety-seven percent of the strains gave at least a 3+ reaction with the homologous group or toxin type reagent. Some cross-reactions occurred with reagents against different toxin type strains within a physiological group; there was less cross-reaction between physiological groups and very little reactivity of C. botulinum reagents with nontoxigenic organisms. Absorption of cross-reacting antibodies was not successful. Certain reagents could be used for presumptive laboratory identification of C. botulinum strains causing botulism, especially in infants. The type G reagent provided a good means of identifying C. botulinum type G, which lacks the lipase marker and whose toxigenicity may be more difficult to demonstrate in mixed cultures. There was a serological relationship between C. botulinum type G and some strains of Clostridium subterminale. This relationship provided evidence of differences between strains of C. botulinum type G isolated in two different countries.
Clostridium botulinum, although designated as a single species, actually comprises a collection of four dissimilar groups of clostridia which possess in common the ability to produce potent neurotoxins which have similar, if not identical, pharmacological modes of action. Smith (10) lists the four groups of C. botulinum as I, proteolytic strains of toxin types A, B, and F; II, non-proteolytic strains of toxin types B, E, and F; III, toxin types C and D; and IV, toxin type G (see Table 1 ). Human botulism is caused primarily, if not exclusively, by organisms of groups I and II. There have been no adequately confirmed human cases caused by groups III or IV. All cases of infant botulism confirmed thus far have been caused by group I organisms, and with one exception (7), the toxin types have always been A or B.
Although no cases of type G botulism, either human or animal, have been documented, Sonnabend et al. have reported the isolation of C. botulinum type G from autopsies of cases of unexplained death in Switzerland (12) . These findings are similar to the finding of type A and B strains in autopsies of a number of cases of sudden infant death syndrome (1) and raise the question of whether the organisms played any role in those deaths. C. botulinum type G is difficult to recognize in mixed cultures because of its lack of lipase and low toxigenicity.
The purpose of our study was to evaluate whether fluorescent-antibody (FA) reagents could be reliably used to detect and identify C. botulinum in fecal specimens and enrichment cultures. If reliable, the use of FA techniques for presumptive diagnosis of botulism would be especially useful at the local level for diagnosing the disease in infants in situations in which mice for toxicity and neutralization tests or the expertise for performing and interpreting those tests may not be available.
We prepared FA reagents against a representative strain of each toxin type within each of the two groups of C. botulinum known to cause human botulism. We then evaluated them against a large number of strains of C. botulinum and other clostridia to determine whether they could be used reliably for diagnostic purposes. Two additional reagents were made, one against Clostridium sporogenes and one against C. botulinum type G. C. sporogenes resembles the group I C. botulinum strains except that it lacks (12) . All strains were identified by the Centers for Disease Control Anaerobe Section by methods described elsewhere (3). For this study, they were rechecked for purity, toxigenicity, and toxin type.
Antigen preparation. The following bacterial strains (antigen strains) were completely retested for their biochemical, physiological, and toxigenic characteristics: MD-00alO, C. botulinum type A; MD-000b2, C. botulinum type B; BL-00706, C. botulinum type B (non-proteolytic); BL-00211, C. botulinum type E (Dolman VH strain); BL-02821, C. botulinum type F; RH-00084, C. botulinum type F (non-proteolytic); BL-00714, C. botulinum type G; and BL02285, C. sporogenes. The type A and B (proteolytic) antigen strains were isolates from infants with botulism, and the type G was the second strain isolated in Argentina. The antigen strains were cultured for short periods before harvesting to ensure the maximum yield of vegetative cells and a minimum of spores, as recommended by Midura et al. (9) . Transfers of the organism were made over a period of 3 days at 4-to 12-h intervals in Schaedler broth (BBL Microbiology Systems, Cockeysville, Md.; catalog no. 12191) or Lombard-Dowell broth (4). The cultures were then centrifuged, and the sedimented cells were washed five times with saline containing 0.4% Formalin and then were suspended in formalinized saline at a density comparable to a McFarland standard no. 3. The cell suspensions were checked for sterility by inoculating 1 ml of the suspension into thioglycolate broth medium. Toxicity was checked by mouse inoculation.
Rabbit immunization. Preimmune blood was drawn by heart puncture from New Zealand rabbits weighing approximately 2.7 kg (40-ml syringe, 20-gauge needle), and the serum was separated and stored at -20°C. After 1 week, the rabbits were immunized intravenously (ear vein) with six injections at 3-to 4-day intervals with increasing amounts of the antigen (1, 2, 3, 4, 5, and 5 ml). One week after the sixth injection, the rabbits were bled by heart puncture. They were bled two or three times, and then a booster of 5 ml of antigen was given to each of the surviving rabbits.
After 8 days, the rabbits were exsanguinated. 
RESULTS
The agglutination titers of the rabbit sera against the immunizing strains and the FA titers and the fluorescein-to-protein ratios of the FA conjugates prepared from them are listed in Table 2 . The reactivity of the group I (types A, B, and F), group II (types B, E, and F), group IV (type G), and C. sporogenes FA reagents with the homologous and heterologous groups of clostridial strains are listed in Table 3 .
Each of the seven C. botulinum FA reagents reacted with at least a 2+ intensity with all of the strains of the same toxin type within the physiological group of the immunizing strain. In fact, except for five strains of type A and one strain of group I type B, the reactions with the homologous reagents were 3+ or better. The C. sporogenes reagent reacted with only 7 of the 15 strains of C. sporogenes at an intensity of 2+ or greater. There was considerable cross-reactivity within the physiological groups I and II. Note especially the cross-reactions between toxin types B and F in group II. The type A reagent reacted with three nontoxigenic organisms (one resembling type E and two strains of C. sporogenes), and the B (group I) reagent reacted with four (two resembling type E, and one strain of C. sporogenes, and one of C. histolyticum). The type G reagent reacted with two strains of C. subterminale.
Absorption studies with cross-reacting species. Attempts to improve the specificity of the types A, B (group I), and G reagents by absorption with cross-reactive species gave results which are summarized in Table 4 . Absorption of the type A reagent with a strain of C. sporogenes removed the cross-reacting antibodies and did not lower the FA titer for the immunizing strain but did destroy its usefulness for detecting C. botulinum type A. The attempted absorption of the B reagent with C. histolyticum failed to remove the cross-reacting antibodies. The absorption of the type G reagent with C. subterminale removed the cross-reacting antibodies and rendered the reagent incapable of detecting the five strains of C. botulinum type G previously isolated in Switzerland (12), but it was still potent with regard to the immunizing strain as well as the other (original) isolate from Argentina (5 In conclusion, the results of this study indicate that FA reagents prepared against vegetative cells of C. botulinum can be used to aid in the diagnosis of botulism. In particular, the use of group I reagents can provide a rather high probability of confirming the presence of an organism in stool specimens from infants with botulism. An evaluation of the use of these reagents for examining clinical specimens was carried out, and the results of that study will be reported later. The type G reagent shows promise as a means of identifying C. botulinum type G in clinical specimens.
